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Abstract
Cytochrome P450s are b-heme-containing enzymes that are able to introduce oxygen atoms into a wide variety of
organic substrates. They are extremely widespread in nature having diverse functions at both biochemical and
physiological level. The genome of C. jejuni 81-176 encodes a single cytochrome P450 (Cj1411c) that has no close
homologues. Cj1411c is unusual in its genomic location within a cluster involved in the biosynthesis of outer surface
structures. Here we show that E. coli expressed and affinity-purified C. jejuni cytochrome P450 is lipophilic,
containing one equivalent Cys-ligated heme. Immunoblotting confirmed the association of cytochrome P450 with
membrane fractions. A Cj1411c deletion mutant had significantly reduced ability to infect human cells and was less
able to survive following exposure to human serum when compared to the wild type strain. Phenotypically following
staining with Alcian blue, we show that a Cj1411c deletion mutant produces significantly less capsular
polysaccharide. This study describes the first known membrane-bound bacterial cytochrome P450 and its
involvement in Campylobacter virulence.
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Introduction
During the past few decades Campylobacter has been
identified as the most common cause of bacterial diarrheal
illness in the European Union and worldwide [1]. This pathogen
is also responsible, in some patients, for severe neurological
diseases including Guillain-Barré syndrome [2]. Over 95% of
campylobacteriosis cases are endemic, the rest attributable to
outbreaks, usually due to contaminated private water supplies
or unpasteurised milk [3]. Campylobacter jejuni 81-176 was
originally isolated from a 9-year-old girl with diarrhea, and it
was shown to cause severe disease in human patients [4].
Cytochromes P450s are a superfamily of proteins with a
maximum absorption at 450 nm and are characterized by the
presence of a conserved Cys residue [5]. This cysteine
distinguishes cytochrome P450s from other oxygen activating
enzymes such as globins and peroxidases that utilize histidine
during the reaction with hydroperoxide [6]. The number of
cytochrome P450 proteins encoded in bacteria is variable.
Escherichia. coli, for example, has no cytochrome P450
encoded in its genome, whereas Mycobacterium tuberculosis
contains twenty and Streptococcus coelicolor eighteen P450
cytochromes [7]. . The bacterial cytochrome P450 enzymes
have functions that include camphor degradation [8] and biotin
synthesis [9]. The genome of C. jejuni 81-176 encodes a single
cytochrome P450, Cj1411c (CYP1411c).
The CYP1411c coding sequence is 1359 bp long (453 amino
acids). It is located in a genomic region that mainly encodes
proteins known to be involved in bacterial outer surface
biosynthesis, and amino-acid transferases. The function of the
Campylobacter enzyme cannot be inferred from sequence
comparisons, but the location of the coding sequence at the
downstream end of the large Kps gene region (capsule
biosynthesis cluster) indicates a possible function in the
biosynthesis of cell surface components [10].
Outer surface structures are important in Campylobacter
pathogenesis. They have been shown to be responsible for
adherence and invasion, colonization and disease,
maintenance of cell surface charge and serum resistance
[11-14]. In this study we show that CYP1411c is a membrane-
bound cytochrome P450, that when mutated significantly
impairs C. jejuni 81-176 pathogenicity. In addition, CYP1411c
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protein expression was increased following cellular
internalization and diminished capsular polysaccharides (CPS)
on the outer surface of the CYP1411c deletion mutant was
detected.
Materials and Methods
Bacterial strains and growth conditions
C. jejuni 81-176 wild type and the deletion mutant
Campylobacter jejuni 81-176 ΔCj1411c were grown on Mueller-
Hinton (MH) Agar or in MH Broth (OXOID, UK) at 37°C for 48h
under microaerobic conditions (5% CO2, 5% O2, 90% N2).
HCT-8 cells (human adenocarcinoma cells) were maintained in
RPMI 1640 (Sigma, UK) containing 10% fetal bovine serum.
Cells were grown at 21% O2, 5% CO2 and transferred to
microaerobic conditions for infection studies. The E. coli strains
Nova Blue [endA1 hsdR17 (rK12– mK12+) supE44 thi-1 recA1
gyrA96 relA1 lac F[proA + B+ lacI qZΔM15::Tn10] (TetR)] or
TUNER [F- ompT hsdSB (rB– mB–) gal dcm lacY1(DE3) pLacI
(CamR)] were maintained in either LB Broth or agar with
appropriate antibiotics.
Mutant Construction
To examine the role of CYP1411c in C. jejuni virulence we
have constructed a deletion mutant as previously described
[15]. Two DNA fragments of 400 base pairs were each
amplified by PCR from upstream (P1FOR450 and P1REV450)
and downstream (P2FOR450 and P2REV450) of the Cj1411c
gene. The chloramphenicol cassette originating from PYR112
was inserted by overlapping PCR (CMFOR and CMREV)
between the two 400 base pair DNA fragments. Primer
sequences are shown in Table 1. The resulting deletion
cassette was used to transform C. jejuni 81-176 by natural
transformation [16]. For reconstitution the Cj1411c gene was
cloned into the SmaI site of PRY107 (KmR) plasmid (a non-
suicidal plasmid) and transformed by natural transformation
into the C. jejuni 81-178 ΔCj1411c strain to give C. jejuni
81-178 ΔCj1411c::Cj1411c strain.
Table 1. Primers used.
Primer namePrimer sequence 5’–3’
P1
FOR450 GACAAAATTTAGATTTATCTTTACTTCATAAGTTAAAAATTC
P1
REV450 CTTGGAAAGGAACACCGCCGAGATTTTTACCTTTTCTTCTAA
P2
FOR450 ACCCTTTAGGAACTAAAGGGCGAAAGAGTTAGAACTAAAA
P2
REV450 TGCTTGTCTAAATTTCTTGAAAGTATGAAATCCACCACAGGT
CM FOR CTCGGCGGTGTTCCTTTCCAAG
CM REV CGCCCTTTAGTTCCTAAAGGGT
P450 FOR ATGAGTGAATGCCCCTTTTTTCCAAAACCTTATAAAAATAAAGC
P450 REV TCAGTGGTGGTGGTGGTGGTGTAGCTTTCTTTTGCTAAATTTTAT
doi: 10.1371/journal.pone.0075534.t001
Protein expression, purification and antibody
production
For antibody production the Cj1411c gene was amplified
from C. jejuni 81-176 genomic DNA using primers P450 FOR
and P450 REV. Following amplification by PCR the
recombinant DNA fragment was ligated into the EcoRV site of
the pETBlue1 vector. For initial cloning the ligated vector was
transformed in E. coli Nova Blue and for overexpression in E.
coli TUNER. The overexpression strain was grown in Terrific
Broth with carbenicillin/chloramphenicol at 37 °C until OD600 =
0.5 and induced with 1mM IPTG overnight at room
temperature. Bacterial pellets were harvested and lysed in 25
mM Tris pH7.5, 250 mM NaCl, 25 mM Imidazole, 1 mM DTT,
0.1% Triton X-100 and protease inhibitors (Sigma, UK). E. coli
lysates were loaded onto a HisTrapTM FF column and eluted
with 25 mM Tris 7.5, 250mM NaCl, 0.1% Triton, 1mM DTT on
an AKTApurifier®. Collected samples were desalted and
concentrated on Centricon® devices with a MW 10.000 cut-off
and stored in 25 mM Tris-HCL pH 7.5 at -80°C. Protein identity,
purity and phosphorylation state was analyzed by Coomassie
blue. The protein was eluted with a gradient of 25 mM Tris pH
7.5, 250 mM NaCl, 250 mM Imidazole, 1 mM DTT, 0.1% Triton
X100 and concentrated to 5-10 ml. In order to obtain a higher
purity the concentrated sample was additionally purified on a
Superdex S200 FPLC column in 25 mM Tris pH7.5, 250 mM
NaCl, 1 mM DTT, 0.1% Triton X100. The eluted protein was
concentrated to a volume of approximately 5 ml (100µM). The
purified protein was used for antibody production at Capra
Science (Sweden).
Pathogenicity assay
The gentamicin protection assay was used to test the role of
P450 cytochrome in the ability of C. jejuni 81-176 to adhere
and invade host epithelial cells [14]. Briefly, HCT-8 cells were
grown (60% confluence) for 15 to 18 h in six-well tissue culture
plates at a concentration of 1 × 105 cells per well. Plate grown
C. jejuni 81-176 wild type and C. jejuni 81-178 ΔCj1411c
mutant were washed and re-suspended in tissue culture
medium at an OD600 of 0.4. The HCT-8 cells were washed with
PBS, and 2 ml of fresh culture medium was added to each well.
Bacteria were added to give a multiplicity of infection of 10.
Tissue culture plates were centrifuged at 250 × g for 5 min and
incubated for 3 h at 37°C in 10% CO2. To quantify the number
of cell-associated bacteria, infected monolayers were washed
at least three times with PBS and treated with 0.1% Triton
X-100 in PBS at 37°C for 30 minutes. Tenfold dilutions of each
well were plated onto the appropriate agar and colonies
enumerated after 3 days of incubation. To quantify the number
of bacteria that invaded HCT-8 cells, the infected monolayers
were washed with PBS and tissue culture medium (2 ml)
containing gentamicin (400 μg/ml) was added to half the wells,
and medium with no antibiotic was added to the remaining
wells. The tissue culture plates were then incubated for a
further 2 h at 37°C and washed with PBS. HCT-8 cells were
lysed by the addition of 100μl of 0.1% Triton X-100 in PBS and
incubated for 10 to 15 min at 37°C. Tenfold dilution of the
contents of each well was plated onto the appropriate agar and
colonies were enumerated after 3 days of incubation. Invasion
Cytochrome P450 and Their Role in Pathogenicity
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efficiency was calculated as the average of the total number of
CFU/total initial inoculum. C. jejuni 81-176 passaged in RPMI
1640 (without cells) was also tested for the ability to adhere to
and invade HCT-8 cells. All assays were conducted in triplicate
and repeated independently three times. The significance of
differences in adhesion and invasion between samples was
determined using the Student t test. A P value of <0.05 was
defined as significant.
Cell infection for RNA extraction
HCT-8 cells were seeded on 12 well plates at a density of
108/well and allowed to grow overnight to 60-70% confluence.
Agar-grown bacteria were used to prepare the inocula for
infection experiments. Bacteria were harvested from plates and
suspended in RPMI 1640 medium. Six well plates, containing
HCT-8 cells, were inoculated with 1 ml of bacterial suspension
with OD600 of 0.4. HCT-8 cells were infected at 37°C under
microaerobic conditions (5% O2, 5% CO2, and 90% N2) for 1.5
and 3h. Viable counts were determined for inocula at each
passage (both with and without host cells) to ensure that
similar numbers of live bacteria were present at each stage of
infection and for non-infected controls.
RNA extraction and qPCR
Total RNA was isolated from internalized bacteria by using
the RNeasy Kit (Qiagen). The RNA was reverse transcribed
using the High Capacity cDNA reverse transcription kit (Applied
Biosystems, CA) according to the manufacturer’s protocol. The
mRNA levels were determined by quantitative RT-PCR using
SYBR Green (Applied Biosystems, CA) on a 7900 Fast Real-
Time System (Applied Biosystems, CA) and the primers
qP450F (5’-atgagtgaatgccccttttttcca-3’) and qP450R (5’-
ctcccctaaaagcggacttaaaag-3’). Relative quantity of p450 mRNA
was calculated using the ΔCt method. Universal eubacterial
primers for rRNA 16S were used as an endogenous control
(UniF340-5’-actcctacgggaggcagcagt-3’ and UniR514
-5’attaccgcggctgctggc-3’). For each experiment the RNA was
extracted from 6 wells of infected cells and also from the
bacteria in control experiments in the absence of cells.
CPS staining
CPS was prepared from bacteria as described by Hitchcock
[17]. Bacteria were harvested by centrifugation and suspended
in 100 μl of lysis buffer containing 31.25 mM Tris-HCl (pH 6.8),
4% sodium dodecyl sulfate, 0.025% bromophenol blue, and
20% glycerol. After heating to 100°C for 5 min, 20 μl of the
sample was transferred into a fresh tube, 1 μl of 20 mg/ml
proteinase K was added to the solution, and the tubes were
incubated for 1 h at 50°C. The samples were fractionated on
NuPage Novex 10% bis-Tris gels (Invitrogen, United Kingdom).
Following electrophoresis, gels were stained with Alcian blue
(0.1% Alcian blue in 40% ethanol, 5% acetic acid) [18].
Serum resistance assay
The sensitivity of bacteria to human serum was measured
[19]. C. jejuni 81-176 wild type and Cj1411c deletion mutant
were plate-grown and resuspended in fresh tissue culture
medium (RPMI 1640) to give an OD600 of 0.1. Five microliters of
bacterial suspension was added to duplicate wells of a six-well
plate containing 800 μl of Mueller-Hinton broth and 200 μl of
active pooled human serum or to separate wells containing 800
μl of Mueller-Hinton broth and 200 μl heat-inactivated human
serum to give a total volume of 1ml. The plates were incubated
for 1 h at 37°C under microaerobic conditions. Bacteria from
each well were diluted 10-fold and 50µl plated on dry Mueller-
Hinton agar plates. The plates were incubated at 37°C under
microaerobic conditions. Colony counts were performed after
an incubation time of 2 days. All assays were conducted in
triplicate and repeated independently three times.
Western Blotting
Proteins were separated on 10% SDS polyacrylamide gels
and transferred to 0.45 µm nitrocellulose membrane (Millipore).
Following WB the membranes were blocked in 3% BSA +
0.05% Tween for 30 minutes. Primary antibodies against
Cj1411c P450 (rabbit polyclonal), anti-His (sc-53073, Santa
Cruz Biotechnology) were used. The anti-CadF and anti-Fur
antibodies (rabbit polyclonal) confirmed the purity of our
membrane fractionations. Following washing in PBS-TWEEN
the membranes were incubated with the secondary antibodies
(goat anti-rabbit - #7074S, Cell Signaling; goat anti-mouse
sc-2031, Santa Cruz). Detection was performed with the
PIERCE chemiluminiscence kit (Thermo, Fisher Scientific).
Densitometry was performed using Fiji ImageJ software.
Subcellular fractionation
Bacterial cellular fractionation was performed as previously
described [20]. Bacteria were harvested by centrifugation in
20mM Tris (pH 7.5) at 12000g for 20 minutes at 4°C followed
by washing 3 times in 20mM Tris (pH 7.5). The bacteria were
then disrupted by sonication in 20mM Tris (pH 7.5) with
protease inhibitors (Sigma, UK). In order to collect unbroken
cells we have centrifuged the sonicated material for 10 minutes
at 2000 rpm and kept the supernatant. In order to collect the
total membranes the sonicated material was centrifuged at
40000g for 1 hour at 4°C and the supernatant containing the
cytosolic fraction was collected. In order to separate the inner
membranes from the outer membranes the resulting pellet was
resuspended in 20mM Tris (pH 7.5) containing 2% sodium
lauryl sarcosine and incubated for 30 minutes at 4°C. Following
centrifugation at 40000g for 1 hour at 4°C the supernatant
fraction contains the inner membranes and the outer
membranes are in the pellet. The outer membranes were re-
suspended in 20mM Tris (pH 7.5). The purity of our membrane
fractionations was controlled using an anti-Fur antibody (a
cytosolic protein) and anti-CadF antibody (an outer membrane
protein).
UV-visible spectroscopy
The visible absorption spectra for the purified cytochrome
P450 protein were recorded by using a Shimadzu UV-1650
dual-wavelength/double beam spectrophotometer. The
measurement was performed in a 1 cm path length quartz
cuvette containing 1µM purified protein in 25mM Tris (pH 7.5)
and 200mM KCl. The spectra was recorded between 800-300
Cytochrome P450 and Their Role in Pathogenicity
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nm. For the carbon monoxide (CO) bound spectra CO was
bubbled through the sample for one minute and the spectrum
was recorded as mentioned above.
Results
1. Spectroscopic characterization of the purified
protein
To analyze the cellular localization of Cj1411c and its
biochemical characteristics purified active enzyme and anti-
CYP1411c antibody were essential. The CYP1411c protein
was overexpressed in E. coli Tuner DE3 and purified by 2-step
chromatography. Figure 1(a) shows the successfully purified
cytochrome P450 protein following Coomassie blue staining of
SDS gels. Following successful overexpression and purification
we raised an antibody against CYP1411c for further
characterization by Western blotting, (Figure 1c). Spectroscopy
showed a heme Soret band at 422 nm and a spectrum
characteristic of a low spin ferric active cytochrome P450
(Figure 1b). Addition of 1 mg sodium dithionite caused no
change to the spectrum, indicating that reduction of the heme
to the ferrous form is unfavourable under these conditions [6].
The fact that the heme is unable to be reduced in the purified
enzyme suggests that substrate binding will act as a trigger for
reduction, as is common in cytochrome P450s, by inducing a
reduction potential shift [6]. This can only be tested once the
substrate has been identified. Reduction potential can also be
influenced by environment, and it is possible that the enzyme
needs to be associated with a membrane to be functional in
this respect.
2. The role of Cj1411c in Campylobacter jejuni 81-176
pathogenicity
In order to investigate the role of CYP1411c in C. jejuni
81-176 virulence we constructed a deletion mutant (C. jejuni
81-176 ∆Cj1411c). The deletion strain was reconstituted using
the PYR107 shuttle plasmid (C. jejuni 81-176
∆Cj1411c::Cj1411c) The successful Cj1411c gene deletion was
confirmed by Western blotting using an anti-P450 antibody
(Figure 1c).
Because cytochrome P450s are associated with
pathogenicity in other organisms we investigated the role
CYP1411c in virulence by comparing the adhesion (Figure 2a),
invasion (Figure 2b) of the wild type strain with the CYP1411c
deletion mutant and also with the reconstituted mutant.
Following gentamicin protection assay, the deletion mutant
showed a significant reduction in invasion (P = 0.005), with the
virulence being restored following reconstitution. Levels of
adhesion were unaffected.
We also tested the effect of CYP1411c gene deletion on
serum resistance as it is directly connected to virulence. The
wild type strain had an average rate of survival of 60%.
However, there was a dramatic decrease (23%) in the rate of
survival of the cytochrome P450 deletion strain (P < 0.003).
The reconstituted strain showed restored survival when
compared to the wild type strain (Figure 2c). These results
demonstrate that the CYP1411c is involved in C. jejuni 81-176
Figure 2.  Virulence and serum resitance.  (a) adhesion to
HCT-8 cells, (b) invasion of HCT-8 cells of C. jejuni 81-176 wild
type, C. jejuni 81-176 ΔCj1411c and C. jejuni 81-176
ΔCj1411c::Cj1411c. (c) serum resistance - the survival rate is
defined as the number of C. jejuni 81-176 colonies isolated
following exposure to human serum divided by the number of
colonies surviving in heat inactivated serum, expressed as a
percentage. Statistical significance (Student’s t test) relative to
the level of wild type strain is indicated. *P=0.001. The
experiments were done in triplicate and on three separate
occasions. The error bars represent standard deviations for six
separate wells.
doi: 10.1371/journal.pone.0075534.g002
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Figure 1.  Cj1411c protein and mutant characterization.  (a) Visualization of protein expression using 10% SDS-PAGE and
stained with Coomassie Blue (b) Identification of the 450 nm absorption in the SORET band with CO bound on recombinant
CYP1411c. Successive spectra show the oxidation transition from a 420 nm peak to a 450 nm peak in CYP1411c following
exposure to CO. (c) Western blot analysis with an anti-CYP1411c antibody following gene deletion showing the absence of the
cytochrome P450 protein in C. jejuni 81-176 ΔCj1411c.
doi: 10.1371/journal.pone.0075534.g001
Cytochrome P450 and Their Role in Pathogenicity
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pathogenicity by contributing to its virulence and serum
resistance.
3. CYP1411c gene expression is up-regulated following
invasion of epithelial cells
Next we have investigated the hypothesis that Cj1411c is
important during survival inside the host following
internalization. In order to test this hypothesis we isolated RNA
from bacteria that had infected human epithelial HCT-8 cells for
intervals of 1.5 and 3 hours. We show, using q-PCR, that the
CYP1411c gene expression levels were significantly increased
when C. jejuni attached to or internalized in human intestinal
epithelial cells. In the absence of HCT-8 cells the gene
expression levels remained low whereas the 16S rRNA levels
remained constant (data not shown) (Figure 3). Investigation of
protein levels by Western blotting using the anti-CYP1411c
antibody confirmed the q-PCR results (Figure 3). These results
show that CYP1411c is up-regulated after internalization,
suggesting that this enzyme is metabolically required when the
pathogen invades the host. This could explain the significant
decrease in invasiveness of the deletion mutant (Figure 2b).
4. CYP1411c a membrane-associated cytochrome P450
In order to investigate the subcellular localization of
CYP1411c we have separated cytosolic, inner membrane and
outer membrane proteins from C. jejuni 81-176. Western
blotting on the individual fractions was performed using the
anti-P450 antibody (Figure 4A). CYP1411c was present in all
three fractions, including the inner and outer membrane.
Densitometry on blots showed that 83% of the total CYP1411c
Figure 3.  qRT-PCR analysis of Cj1411c gene expression
during infection.  Cj1411c expression analysis in C. jejuni
81-176 following infection of HCT-8 cells. The gene expression
level for 1.5h in RPMI was set to 1 as the basal level. All other
levels are expressed as fold change over the basal gene
expression. Error bars represent ±S.D. of 3 independent
experiments. The corresponding protein expression levels
assessed by Western blot with the anti-P450 antibody are
shown.
doi: 10.1371/journal.pone.0075534.g003
present in C. jejuni 81-176 was membrane bound. As the
majority of CYP1411c is membrane bound, its redox partners
or possible substrates should be localized within the same
subcellular fraction. In order to check the purity of bacterial
fractionations we have used an anti-Fur antibody, as Fur
protein is a known cytosolic protein (Figure 4B) and an anti-
CadF antibody detection of CadF, a known outer membrane
protein (Figure 4C). Following bacterial fractionation we
investigated by spectroscopy the effect of membrane proteins
on purified CYP1411c absorption spectra. The purified enzyme
was incubated with C. jejuni 81-176 inner membrane fractions
for overnight, followed by the addition of dithionite, which
caused a slow shift in the Soret band from 422 to 400 nm and
the merging of the α and β bands. Such an effect is
characteristic of a low to high spin transition in cytochrome
P450s, often observed on substrate binding (Figure 5). The
spin-state change facilitates reduction of the protein, which was
also observed in this case. Our results show that C. jejuni
81-176 inner membrane proteins can cause an alteration in
spectra, suggesting an interaction with purified CYP1411c.
Such changes in spectra were not observed when probed with
cytosolic fractions from C. jejuni 81-176. This result confirms
that either the redox partner or the substrate of CYP1411c is
localized within this bacterial fraction and is important for
enzyme function. This data identifies the CYP1411c as the first
bacterial cytochrome P450 to be membrane-associated.
5. CYP1411c is involved in outer surface biosynthesis
In light of the unique position of this cytochrome P450 in the
capsule biogenesis locus, and the effect of deleting Cj1411c on
pathogenicity, we hypothesized that the cytochrome P450
protein is involved in or contributes to CPS (capsule
polyssacharide) production. We extracted CPS from C. jejuni
81-176 wild type, ΔCj1411c deletion mutant and
ΔCj1411c::Cj1411c reconstituted mutant. Following separation
in SDS gels, staining with Alcian blue was performed. As
depicted in Figure 6 the CYP1411c mutant (Figure 6, lane 3)
displayed significantly reduced CPS and LOS staining when
compared to the wild type strain (Figure 6, lane 2). The
recovery of staining in the reconstituted mutant (Figure 6, lane
4) indicates clearly that CYP1411c impacts on the biosynthesis
of these structures.
Discussion
Cytochrome P450s comprise an important group of proteins
involved in the synthesis of physiologically active compounds,
drug metabolism and bioconversion of xenobiotics. Although
the C. jejuni 81-176 genome database annotation identifies
only one cytochrome P450, no data are available on the
possible functions of this protein. Overexpression of the protein
in E. coli and antibody production allowed us to identify this
cytochrome not only in cytosolic fractions but also in membrane
fractions. This is consistent with data obtained from
bioinformatics that place this cytochrome within a genomic
cluster involved in biosynthesis of outer surface structures
(http://www.sanger.ac.uk). While other known prokaryotic
cytochrome P450s are cytosolic proteins, the eukaryotic
Cytochrome P450 and Their Role in Pathogenicity
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Figure 4.  CYP1411c cellular localization.  (A) Anti-P450
immunoblotting on bacterial fractions (cytosolic fraction, Cyt;
inner membrane protein, IMP and outer membrane protein
fraction, OMP). Recombinant CYP1411c protein (purified) was
used as a positive control. Fractions were validated with an
antibody recognizing the cytosolic Fur protein (B) and the outer
membrane protein CadF (C).
doi: 10.1371/journal.pone.0075534.g004
Figure 5.  CYP1411c spectral change following incubation
with the inner membrane fraction.  IMP o/n 1-5 represent
successive spectral recordings following incubation of purified
CYP1411c protein with C. jejuni 81-176 inner membrane
proteins. Spectra were recorded at 1 min intervals.
doi: 10.1371/journal.pone.0075534.g005
enzymes are known to be integral membrane proteins [21].
This common feature of mammalian cytochrome P450s is
important, because their catalytic domain is facing the cytosol
allowing them to bind liposoluble substrates [22]. In our
experiments we have identified Cj1411c as being
predominantly localized in the outer membrane fraction. While
not unambiguously confirming this location, the control
Figure 6.  The effect of Cj1411c gene deletion on CPS
production.  Alcian blue stained CPS of C. jejuni 81-176 wild
type (lane 2) was compared with the CPS extracted C. jejuni
81-176 ΔCj1411c (lane 3) and C. jejuni 81-176
ΔCj1411c::Cj1411c (lane 4).
doi: 10.1371/journal.pone.0075534.g006
Cytochrome P450 and Their Role in Pathogenicity
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experiments, using known cytosolic and membrane proteins,
support this finding. We speculate that the cytochrome P450
enzyme substrate is membrane localized in Campylobacter
and that the cytosolic fraction of the CYP1411c enzyme might
only be required during the catalytic cycle in electron
scavenging. These hypotheses require further investigation.
The biochemical studies performed on purified protein
suggest that the reduction potential of the heme is very low. A
similar situation is observed with the F393W mutant of
P450BM3 [6]. A slow shift in the Soret band to 447 nm
indicated formation of the cytochrome P450 ferrous CO
complex characteristic of Cys-thiolate ligated heme when CO
gas was added to the sample (Figure 1B). Thus, CO is able to
induce the heme into the ferrous form, not accessible in the
presence of dithionite only. Observation of a Cys-ligated
ferrous heme CO complex confirms that CYP1411c is a typical
cytochrome P450, and was purified with the protein-heme
ligand complex intact. The change in absorption following
interaction with inner membrane fractions represents a key
result for its functionality. It is important for cytochrome P450s
to have redox partners in the vicinity because they require two
electrons for their catalytic function and these are usually
supplied in two consecutive steps from NAD(P) H via the redox
partners. Interestingly one of the predicted redox partners for
CYP1411c is an iron-sulfur protein (Cj0074c), known to be
localized within the inner membrane fraction [23].
In C. jejuni 81-176, outer surface components are actively
involved in mediating its pathogenicity. The unique localization
of CYP1411c at the end of the surface biosynthesis cluster
suggested its possible association with bacterial membranes
and involvement in the formation of surface components. The
CYP1411c deletion mutant is significantly less virulent than
wild type C. jejuni 81-176. The decrease in virulence was
accompanied by loss of resistance to human serum. One of the
outer surface features associated with attenuated virulence is
the capsule polysaccharide (CPS). The CYP1411c deletion
mutant produced significantly less CPS than the wild type C.
jejuni 81-176 strain. Previous studies demonstrated that loss of
CPS can impair the ability of C. jejuni to invade human cells
providing a possible explanation for the attenuation of C. jejuni
∆Cj1411c invasiveness [14,20,24,25].
The significant increase in gene and protein expression of
CYP1411c after invasion of the host, associated with the loss
in pathogenicity of the deletion mutant, highlights the
importance of this cytochrome P450 in host-pathogen
interaction. Involvement of CYP1411c in pathogenicity has
been described also in other pathogens. For example M.
tuberculosis CYP125 is involved in catabolism of host
cholesterol generating immunomodulatory compounds to
increase survival in the host [26]. The role of cytochrome
P450s in survival within the host goes beyond the bacterial
regnum. A similar role was shown for CYP5122A1, a
cytochrome P450 from the parasite Leishmania donovani. In
this parasite CYP5122A1 was linked to processes including cell
growth, infection and ergosterol biosynthesis [27].
Conclusion
In summary C. jejuni CYP1411c is uniquely located in the
membrane fractions of this organism and plays a role in CPS
production. Its role in pathogenicity points to its potential as a
drug target. Further studies are required to elucidate the
complex biological role of this protein.
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